|
Mr. Taylor joined Oscient Pharmaceuticals in 1997 and established the Company's first in-house Investor Relations and Corporate Communications department. In his tenure at Oscient Pharmaceuticals, Mr. Taylor has served as a primary interface with the investment community and has helped lead the Company's financing efforts, investor outreach and corporate news distribution. Previously, he was a Vice President at Feinstein Kean Healthcare, and worked as a Staff Writer in Shareholder Relations at The Putnam Companies. He began his career at Hill & Knowlton, working in Boston and Dallas. Mr. Taylor earned a B.S. in Public Relations from Syracuse University's Newhouse School of Public Communications where he graduated with honors. | 